Scientists launch trial to test whether brain training could help people lose weight
Researchers at Cardiff University have launched a new app called “Restrain” to test whether it is possible to lose weight […]
PARIS (Reuters) -A Paris court on Monday found French drugmaker Servier guilty of manslaughter and deception over weight-loss pill Mediator, […] A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at […] Scientists at Fred Hutchinson Cancer Research Center believe they’ve found a better of use of mobile technology to help adult […] (HealthDay)—A vaccine based on cutting-edge RNA gene technology showed promising potency against the new coronavirus in an early trial, scientists […] Results from a randomized clinical trial have shown that a potential new treatment can help control the immune response of […] BOSTON, Dec. 13, 2018 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization […] San Mateo, Calif, Nov 14, 2018 – Attenua, Inc., a clinical-stage biopharmaceutical company focused on developing novel medicines to treat […] DUBLIN, Aug. 1, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) today announced positive four-week results from a […] JERUSALEM–(BUSINESS WIRE)–Jun. 15, 2018– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a change in the clinical development […]trial
Paris court fines Servier 2.7 million euros over weight-loss drug
Trial will test existing drugs against rare blood cancer
Fred Hutch-led clinical trial shows new smartphone app helps smokers quit
Pfizer’s COVID vaccine shows ‘robust’ results in early trial
New insights from first clinical trial of potential treatment for motor neurone disease
Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline
Theravance Biopharma Reports Positive Top-Line Four-Week Data from Phase 2 Trial of TD-9855 for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension
Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache